Advertisement
Advertisement
U.S. Markets open in 7 hrs 43 mins
Advertisement
Advertisement
Advertisement
Advertisement

Beijing Kawin Technology Share-Holding Co., Ltd. (688687.SS)

Shanghai - Shanghai Delayed Price. Currency in CNY
Add to watchlist
17.30-0.01 (-0.06%)
As of 01:30PM CST. Market open.
Advertisement

Beijing Kawin Technology Share-Holding Co., Ltd.

Building 3, No. 6, Rongjing East Street
Beijing Economic and Technological Development Zone
Beijing 100176
China
86 10 6789 2271
https://www.kawin.com.cn

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees647

Description

Beijing Kawin Technology Share-Holding Co., Ltd. engages in the development and production of pharmaceutical products primarily in the areas of liver diseases in China. The company's products include recombinant human interferon alfa-2b injection and compound glycyrrhizin. It provides active pharmaceutical ingredients; clinical research services for biological product development, which include drug substances–fermentation and purification, drug product–formulation, and analytical methods development; and contract manufacturing services. The company also serves customers in Pakistan, Colombia, Philippines, Vietnam, Russia, Cambodia, and others. It has strategic partnership with Legend Capital, Haitong Capital, and Cybernaut. The company was founded in 2008 and is based in Beijing, China.

Corporate Governance

Beijing Kawin Technology Share-Holding Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement